Dr. Gibson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Summary
- Dr. Michael Gibson is an oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including University Hospitals Cleveland Medical Center and Vanderbilt University Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 20 years. He specializes in gastrointestinal cancer, hiv/aids related, head & neck cancer, and hematologic oncology and is experienced in lung cancer, head and neck oncology, thyroid neoplasms, gastrointestinal oncology, and general medical oncology.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2000 - 2004
- Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
- TN State Medical License 2017 - 2025
- AL State Medical License 2020 - 2020
- OH State Medical License 2013 - 2019
- PA State Medical License 2007 - 2014
- MD State Medical License 1999 - 2008
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer Start of enrollment: 2005 Jul 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 336 citationsRandomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Ea...Michael K. Gibson, Yi Li, Barbara A. Murphy, Maha Hussain, Ronald C. DeConti
Journal of Clinical Oncology. 2005-05-20 - 679 citationsGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Jaffer A Ajani, Thomas A D'Amico, David J Bentrem, Joseph Chao, David Cooke
Journal of the National Comprehensive Cancer Network. 2022-02-01 - 458 citationsOesophageal carcinoma.Arjun Pennathur, Michael K Gibson, Blair A Jobe, James D Luketich
Lancet. 2013-02-02
Other
- Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagusGibson MK, Choi NC
http://www.uptodate.com/contents/radiation-therapy-chemoradiotherapy-neoadjuvant-approaches-and-post
UpToDate, Wolters Kluwer Health - 2013-03-28 - Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomasGibson MK, Atasoy A, Berry MF
http://www.uptodate.com/contents/multimodality-approaches-to-potentially-resectable-esophagogastric-
UpToDate, Wolters Kluwer Health - 2013-03-22 - Epidemiology, pathobiology, and clinical manifestations of esophageal cancerGibson MK, Sampliner RE
http://www.uptodate.com/contents/epidemiology-pathobiology-and-clinical-manifestations-of-esophageal
UpToDate, Wolters Kluwer Health - 2012-12-07 - Join now to see all
Press Mentions
- Michael Gibson Votes with FDA Panel to Limit Immunotherapy IndicationOctober 30th, 2024
- University Hospitals Seidman Cancer Center Enrolls First Patient in New National Head and Neck Cancer StudyFebruary 23rd, 2017
- Dr. Michael Gibson&Carly O'Brien–New Treatment Helps Those Suffering W/ Head & Neck Cancer 12.28.16December 28th, 2016
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: